Plasma metabolites in patients of the REDINSCOR III registry hospitalised for de novo heart failure with preserved ejection fraction: Prognostic implications of linoleamide and 2‐trans,4‐cisdecadienoylcarnitine levels.

Saved in:
Bibliographic Details
Title: Plasma metabolites in patients of the REDINSCOR III registry hospitalised for de novo heart failure with preserved ejection fraction: Prognostic implications of linoleamide and 2‐trans,4‐cisdecadienoylcarnitine levels.
Authors: Delgado‐Arija, Marta1,2 (AUTHOR), Dolores García‐Cosío Carmena, M2,3 (AUTHOR), Martínez‐Sellés, Manuel2,4 (AUTHOR), Guerra, José M2,5 (AUTHOR), Valdivielso, Sandra6 (AUTHOR), González‐Juanatey, José R2,7 (AUTHOR), Rivas‐Lasarte, Mercedes2,8 (AUTHOR), Roselló‐Lletí, Esther1,2 (AUTHOR) esther_rosello@iislafe.es, Pérez‐Villacastín, Julián2,9 (AUTHOR), Carrasquer, Anna10 (AUTHOR), Matute‐Blanco, Lucía11 (AUTHOR), Grande‐Trillo, Antonio12 (AUTHOR), Crespo‐Leiro, Maria Generosa2,13 (AUTHOR), Delgado, Juan F2,3 (AUTHOR), Martínez‐Dolz, Luis1,2,14 (AUTHOR)
Source: Clinical & Translational Medicine. Sep2025, Vol. 15 Issue 9, p1-5. 5p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20011326
DOI:10.1002/ctm2.70398